Cargando…

Is there a relationship between factor V Leiden and type 2 diabetes?

BACKGROUND: Diabetes is well known risk factor for thrombotic events. The association between diabetes and venous thromboembolism is still matter of debate. However, during diabetes an acquired thrombophilia is present and is due to the non-enzymatic glycosilation of clotting inhibitors as antithrom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lodigiani, Corrado, Ferrazzi, Paola, Di Micco, Pierpaolo, Librè, Luca, Genovese, Stefano, Quaglia, Ilaria, Rota, Lidia Luciana
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2708136/ https://www.ncbi.nlm.nih.gov/pubmed/19558686 http://dx.doi.org/10.1186/1479-5876-7-52

Ejemplares similares

Differences in the INR evaluation of two different thromboplastins in patients with positivity to lupus anticoagulant in ongoing oral anticoagulation
por: Ferrazzi, Paola, et al.
Publicado: (2010)

SV-IV Peptide1–16 reduces coagulant power in normal Factor V and Factor V Leiden
por: Di Micco, Biagio, et al.
Publicado: (2007)

Intima-media thickness evolution after treatment with infliximab in patients with rheumatoid arthritis
por: Di Micco, Pierpaolo, et al.
Publicado: (2009)

Homocysteine, MTHFR C677T gene polymorphism, folic acid and vitamin B 12 in patients with retinal vein occlusion
por: Ferrazzi, Paola, et al.
Publicado: (2005)

Compromised Lung Volume and Hemostatic Abnormalities in COVID-19 Pneumonia: Results from an Observational Study on 510 Consecutive Patients
por: Lanza, Ezio, et al.
Publicado: (2021)

Venous Thromboembolism and Its Association with COVID-19: Still an Open Debate
por: Di Micco, Pierpaolo, et al.
Publicado: (2020)

Idiopathic Hypereosinophilia and Venous Thromboembolism: Is There a Pathophysiological or Clinical Link? Description of an Intriguing Clinical Case
por: Di Micco, Pierpaolo, et al.
Publicado: (2020)

Fondaparinux and bleeding risk in COVID-19: unsolved question
por: Russo, Vincenzo, et al.
Publicado: (2021)

In vitro Fertilization Procedures with Embryo Transfer and Their Association with Thrombophilia, Thrombosis and Early Antithrombotic Treatments
por: Di Micco, Pierpaolo, et al.
Publicado: (2020)

Clotting Factors in COVID-19: Epidemiological Association and Prognostic Values in Different Clinical Presentations in an Italian Cohort
por: Di Micco, Pierpaolo, et al.
Publicado: (2020)

Prognostic Value of Fibrinogen among COVID-19 Patients Admitted to an Emergency Department: An Italian Cohort Study
por: Di Micco, Pierpaolo, et al.
Publicado: (2020)

Factor V Leiden and Inflammation
por: Perez-Pujol, Silvia, et al.
Publicado: (2012)

Clinical impact of pre-admission antithrombotic therapy in hospitalized patients with COVID-19: A multicenter observational study
por: Russo, Vincenzo, et al.
Publicado: (2020)

The relationship between FV Leiden and pulmonary embolism
por: Hooper, W Craig, et al.
Publicado: (2002)

Pathophysiology of Vaccine-Induced Prothrombotic Immune Thrombocytopenia (VIPIT) and Vaccine-Induced Thrombocytopenic Thrombosis (VITT) and Their Diagnostic Approach in Emergency
por: Di Micco, Pierpaolo, et al.
Publicado: (2021)

Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy
por: Lodigiani, Corrado, et al.
Publicado: (2020)

Wolfgang Pauli in Leiden
por: Unknown
Publicado: (1953)

Perioperative Management of Factor V Leiden and Pancreatic Adenocarcinoma
por: O'Malley, Thomas J., et al.
Publicado: (2017)

Factor V Leiden interferes with protein S activity assay
por: Panaget, Baptiste, et al.
Publicado: (2023)

Catastrophic antiphospholipid syndrome in a patient with V Leiden variant
por: Buscemi, Silvio, et al.
Publicado: (2012)

Myotonic Dystrophy-1 Complicated by Factor-V (Leiden) Mutation
por: Finsterer, Josef, et al.
Publicado: (2015)

Combination of factor V Leiden and MTHFR mutations in myocardial infarction
por: Fekih-Mrissa, Najiba, et al.
Publicado: (2013)

Sclerosing Mesenteritis in a Patient Heterozygous for Factor V Leiden
por: Reddington, Hayley, et al.
Publicado: (2020)

Effects of factor v Leiden polymorphism on the pathogenesis and outcomes of preeclampsia
por: Ababio, G. K., et al.
Publicado: (2019)

Apples in Amsterdam and oranges in Leiden
por: Koster, R. W.
Publicado: (2014)

Relationship between Factor V Leiden Gene Variant and Risk of Ischemic Stroke: A Case–Control Study
por: Kumar, Amit, et al.
Publicado: (2017)

Possible impact of factor V Leiden genotype on warfarin induced bleeding
por: Gaikwad, Tejasvita, et al.
Publicado: (2013)

Factor V Leiden mutation: An added risk in single ventricle palliation
por: Saileela, R, et al.
Publicado: (2012)

Multiple Brain Abscesses in an Immunocompetent Patient With Factor V Leiden Mutation
por: Zafar, Saeed Zubair, et al.
Publicado: (2016)

Factor V Leiden Mutation Frequency and Geographical Distribution in Turkish Population
por: Yıldız, Eray, et al.
Publicado: (2020)

Homozygous factor V leiden mutation: Rare etiology of pulmonary embolism
por: el marraki, Zakaria, et al.
Publicado: (2022)

Ophthalmic Vein Thrombosis Associated with Factor V Leiden and MTHFR Mutations
por: Teodoru, Cosmin Adrian, et al.
Publicado: (2023)

The Impact of Risk-Adjusted Heparin Regimens on the Outcome of Patients with COVID-19 Infection. A Prospective Cohort Study
por: Di Micco, Pierpaolo, et al.
Publicado: (2021)

Testing differences statistically with the Leiden ranking
por: Leydesdorff, Loet, et al.
Publicado: (2012)

The relationship of the factor V Leiden mutation or the deletion-deletion polymorphism of the angiotensin converting enzyme to postoperative thromboembolic events following total joint arthroplasty
por: Della Valle, Craig J, et al.
Publicado: (2001)

Deficiencies of proteins C, S and Antithrombin and factor V Leiden and the risk of ischemic strokes
por: Soare, AM, et al.
Publicado: (2010)

Coagulopathy triggered autoimmunity: experimental antiphospholipid syndrome in factor V Leiden mice
por: Katzav, Aviva, et al.
Publicado: (2013)

The Association of Coagulation Factor V (Leiden) and Factor II (Prothrombin) Mutations With Stroke
por: Pirhoushiaran, Maryam, et al.
Publicado: (2014)

Recurrent pregnancy loss: can factor V Leiden mutations be a cause
por: Reddy, R R N, et al.
Publicado: (2019)

Polymorphisms associated with type 2 diabetes in familial longevity: The Leiden Longevity Study
por: Mooijaart, Simon P., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_6377hgnroddkeesqgr4n30hle5